*Parathyridaria percutanea,* earlier known as *Roussoella percutanea* in the order *Pleosporales,* has been reported to cause subcutaneous phaeohyphomycoses ([@R1],[@R2]). *P. percutanea* belongs to coelomycetes, a group of fungi in which the conidia or asexual propagules lie within a cavity. *Parathyridaria* spp. generally exist as plant saprobes; *P. percutanea* is the only species reported as an opportunistic pathogen.

We recently observed a case of subcutaneous phaeohyphomycosis caused by *P. percutanea.* The patient was a 33-year-old man who had ACTH-dependent Cushing's disease with 2 cutaneous lesions, one under the left axilla and the other on the ulnar aspect of the left forearm, that had progressed slowly over 3 years ([Appendix](#SD1){ref-type="local-data"} Figure 1, panel A). Direct microscopy of a biopsy sample taken from the left forearm lesion revealed dematiaceous septate hyphae with irregular hyphal swellings ([Appendix](#SD1){ref-type="local-data"} Figure 1, panel B). Colonies on Sabouraud's dextrose agar at 25°C were flat, spreading with sparse aerial hyphae after 1 week, and later turned to cottony greenish-black growth ([Appendix](#SD1){ref-type="local-data"} Figure 1, panel C). Lactophenol cotton blue mount revealed nonsporulating dematiaceous hyphae with chlamydospores ([Appendix](#SD1){ref-type="local-data"} Figure 1, panel D). Several attempts to induce sporulation (on oatmeal agar and malt extract agar) failed. Histopathologic examination ([Appendix](#SD1){ref-type="local-data"} Figure 1, panels E--G) showed neutrophilic infiltration with fungal hyphae, nodular swellings on Giemsa stain, and black hyphae on Grocott-Gomori's methamine silver stain.

We identified the fungus as *Roussoella percutanea* of the order *Pleosporales,* later renamed *P. percutanea,* by PCR sequencing of the internal transcribed spacer (ITS) and 28S regions of ribosomal DNA, as described previously ([@R3])*.* ITS sequencing of our strain NCCPF104001 (GenBank accession nos. MG708109 \[by ITS\] and MG708116 \[by 28S\]) had 99.8% identity with CBS128203 (type strain, GenBank accession no. KF322117) and CBS868.95 (GenBank accession no. KF322118), whereas 28S sequences had 100% identity with CBS128203 (GenBank accession no. KF366448) and CBS868.95 (GenBank accession no. KF366449) ([Appendix](#SD1){ref-type="local-data"} Figure 2, panels A. B). The patient refused further treatment in the hospital and left against medical advice.

We screened all the isolates deposited in our National Culture Collection of Pathogenic Fungi (NCCPF, Chandigarh) and characterized them phenotypically as *Pleosporales*. Of 7 such isolates, we identified 4 as *P. percutanea* by sequencing ([Table](#T1){ref-type="table"}). We further subjected these isolates to phylogenetic analysis of ITS and large ribosomal subunit (28S) of the rDNA using MEGA software version 6 (<https://megasoftware.net>) ([@R3]). The strains identified as *P. percutanea* clustered together with the ITS and 28S sequences of CBS12608 and CBS868.95 strains, the other 2 *P. percutanea* isolates reported with gene sequences ([@R2]). Phylogenetically, *Parathyridaria* is now a distinct genus and clearly separated from closely related genera such as *Roussoella* and *Thyridaria* ([Appendix](#SD1){ref-type="local-data"} Figure 2, panels A, B).

###### Comparison of demographic, clinical, and microbiological features of subcutaneous phaeohyphomycosis due to *Parathyridaria percutanea*

  Case no.                 Study or isolate ID         Age, y/ sex   Residing country; native country    Risk factor (time since)                Site                        Diagnostic modality           Molecular targets                       GenBank accession nos., ITS/28S   AFST                          Treatment                                        Outcome
  ------------------------ --------------------------- ------------- ----------------------------------- --------------------------------------- --------------------------- ----------------------------- --------------------------------------- --------------------------------- ----------------------------- ------------------------------------------------ -----------------------
  1                        ([@R5])†                    63/M          The Netherlands; Aruba, Caribbean   Renal tx (2 y)                          Rt lateral foot             Culture                       Misidentified as *M. mycetomatis* ITS   KF322118/ KF366449                Low MIC to VR, PS, IT†        Multiple aspiration of pus + surgical excision   Healed, no recurrence
  2                        ([@R2])                     45/M          United States; India                None; tattoo on the site‡ (2 y); DM     Lt lateral foot and ankle   Culture                       ITS                                     KF322117/ KF366448                Low MIC to VR, PS, IT         Azole therapy for 4 mo + surgical excision§      LTFU
  3                        ([@R6])                     65/M          France; Congo                       Renal tx (1 y)                          Lt lateral malleoli         HPE; No culture sent          NA¶                                     NA                                ND                            PS + surgical excision                           ND
  4                        ([@R7])                     55/F          Germany; Somalia                    Renal and pancreatic tx (3 y)           Lt knee synovial bursitis   GMS staining and culture      ITS                                     NA                                Low MIC to azole VR, PS, IT   VR for 1 mo + surgical excision                  Healed, No recurrence
  5                        ([@R8])                     47/M          United Kingdom; India               Renal tx (1.5 y)                        Rt Achilles                 Calcofluor and PAS stain      ITS, 28S                                NA                                ND                            VR for 2 weeks + surgical excision               Healed. No recurrence
  Reported in this study                                                                                                                                                                                                                                                                                                                                            
  6                        NCCPF 104001 (index case)   35/M          India (Chandigarh); India           ACTH-dependent Cushing's syndrome       Lt forearm and axilla       KOH, Calcofluor and culture   ITS, 28S                                MG708109/ MG708116                NCO                           None                                             LTFU
  7                        NCCPF 104003; ([@R4])\#     47/M          India (Andhra Pradesh); India       Post--renal transplant                  Great toe                   KOH and culture               ITS, 28S                                MG708107/ MG708115                NCO                           VR                                               Healed, no recurrence
  8                        NCCPF 104004                54/F          India (Delhi); India                Interstitial lung disease on steroids   Elbow, knee                 KOH and culture               ITS, 28S                                MG708106/ MG708114                NCO                           Surgical excision and VR                         Healed, no recurrence
  9                        NCCPF 104005                45/M          India (Andhra Pradesh); India       Post--renal transplant                  Foot                        KOH and culture               ITS, 28S                                MG708105/ MG708113                NCO                           None                                             LTFU
  10                       NCCPF 104006                50/M          India (Bangalore); India            Post--renal transplant                  Rt foot                     KOH and culture               ITS, 28S                                MG708108/NA                       NCO                           None                                             LTFU

\*AFST, antifungal susceptibility testing; DM, diabetes mellitus; GMS, Grocott methenamine silver; HPE, histopathological examination; IT, itraconazole; ITS, internal transcribed spacer; Lt, left; LTFU, lost to follow-up; MIC, minimal inhibitory concentration; NA, not applicable; NCCPF, National Culture Collection for Pathogenic Fungi; NCO, not carried out; ND, not documented; PAS, periodic acid--Schiff; PS, posaconazole; Rt, right; Tx, transplant; VR, voriconazole. †Ahmed et al. ([@R2]) studied the culture originally reported by Meis et al ([@R5]). ‡Immunocompetent patient with a tattoo at the site of infection; diabetes mellitus was diagnosed incidentally when patient sought care. §Posaconazole was discontinued (due to gastrointestinal intolerance) and switched to voriconazole, which was also discontinued (due to visual disturbances) and changed to itraconazole. ¶Panfungal PCR done but no targets mentioned ([@R6]).  \#Case described earlier as an "uncommon black fungus belonging to order *Pleosporales*" ([@R10]) was identified at NCCPF. This case is described again in the study series as *P. percutanea*.

We searched published literature on Medline and PubMed for subcutaneous phaeohyphomycoses caused by *P. percutanea* or *R. percutanea* and identified 5 cases ([Table](#T1){ref-type="table"}). All 5 patients originated from tropical countries including the Caribbean islands ([@R5]), Republic of the Congo ([@R6]), Somalia ([@R7]), and India ([@R2],[@R8]). Including these 5 with the case-patients we identified from culture and our study patient, 7 of 10 total cases originated in India. The patients had lesions in the extremities; we expect that the fungus is present in our environment and gains access from traumatic inoculation of patients working in the field or walking barefoot. The clinical description of all 10 patients is presented in the [Table](#T1){ref-type="table"}. Male patients outnumbered female patients. In 2 patients, underlying muscle tendon ([@R2]) and joint bursa ([@R7]) were involved. No discharging sinus or granuloma formation was seen in any of the 10 patients.

*P. percutanea* infection occurred in immunosuppressed patients; 9/10 patients were either renal transplant recipients (7 patients) or on steroid therapy (2 patients). The disease manifested 1--3 years posttransplant. Incidence of subcutaneous phaeohyphomycoses is reported in [\<]{.ul}3.6% of renal transplant recipients ([@R10]). The tenth patient had diabetes, and the infection of *P. percutanea* occurred at a tattoo site, manifesting 2 years after tattooing. The fungus may remain dormant in subcutaneous tissue after traumatic inoculation and multiply slowly at the opportune time when host immunity is depressed because of immunosuppression or diabetes.

The outcome of *P. percutanea* infection was known in 5/10 patients, and they responded to surgical resection of the lesion followed by voriconazole therapy. The joint guidelines of the European Society of Clinical Microbiology and Infectious Diseases Fungal Infection Study Group and the European Confederation of Medical Mycology on the management of subcutaneous phaeohyphomycosis ([@R9]) recommended surgical resection (recommendation AII) along with oral azoles in immunosuppressed patients to prevent dissemination of disease (recommendation BIII). In vitro susceptibility testing, conducted for 3 isolates by Ahmed et al. ([@R2]) and Almagro-Molto et al. ([@R7]), revealed that *P. percutanea* exhibited low MIC to itraconazole, voriconazole, and posaconazole ([Table](#T1){ref-type="table"}). Therefore, itraconazole and posaconazole can be used in patients receiving other liver-metabolized drug therapies.

Especially in renal transplant patients in India, *P. percutanea* could be a possible etiologic agent of subcutaneous phaeohyphomycosis. Sequencing of ITS and 28S regions of ribosomal DNA confirms diagnosis. Effective treatment could include surgical excision of lesions and voriconazole or posaconazole therapy.

###### Appendix

Additional information about *Parathyridaria* infection causing subcutaneous phaeohyphomycosis.
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